These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23552120)

  • 1. Spironolactone improves endothelial and cardiac autonomic function in non heart failure hemodialysis patients.
    Flevari P; Kalogeropoulou S; Drakou A; Leftheriotis D; Panou F; Lekakis J; Kremastinos D; Vlahakos DV
    J Hypertens; 2013 Jun; 31(6):1239-44. PubMed ID: 23552120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes.
    Davies JI; Band M; Morris A; Struthers AD
    Diabetologia; 2004 Oct; 47(10):1687-94. PubMed ID: 15365622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone in chronic hemodialysis patients improves cardiac function.
    Taheri S; Mortazavi M; Shahidi S; Pourmoghadas A; Garakyaraghi M; Seirafian S; Eshaghian A; Ghassami M
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):392-7. PubMed ID: 19414940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure.
    Shah NC; Pringle SD; Donnan PT; Struthers AD
    J Hypertens; 2007 Nov; 25(11):2345-51. PubMed ID: 17921831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B; Zannad F; Remme WJ; Cody R; Castaigne A; Perez A; Palensky J; Wittes J
    N Engl J Med; 1999 Sep; 341(10):709-17. PubMed ID: 10471456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment.
    Macdonald JE; Kennedy N; Struthers AD
    Heart; 2004 Jul; 90(7):765-70. PubMed ID: 15201246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure.
    Korkmaz ME; Müderrisoğlu H; Uluçam M; Ozin B
    Am J Cardiol; 2000 Sep; 86(6):649-53. PubMed ID: 10980217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).
    Vardeny O; Wu DH; Desai A; Rossignol P; Zannad F; Pitt B; Solomon SD;
    J Am Coll Cardiol; 2012 Nov; 60(20):2082-9. PubMed ID: 23083787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone is secure and reduces left ventricular hypertrophy in hemodialysis patients.
    Feniman-De-Stefano GM; Zanati-Basan SG; De Stefano LM; Xavier PS; Castro AD; Caramori JC; Barretti P; Franco RJ; Martin LC
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):158-67. PubMed ID: 26116627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S; Van Israël N; Vanbelle S; Clercx C; McEntee K
    J Vet Pharmacol Ther; 2011 Aug; 34(4):322-31. PubMed ID: 20950346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure.
    Cicoira M; Rossi A; Bonapace S; Zanolla L; Perrot A; Francis DP; Golia G; Franceschini L; Osterziel KJ; Zardini P
    Am J Med; 2004 May; 116(10):657-61. PubMed ID: 15121491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure and chronic kidney disease: should we use spironolactone?
    Agrawal S; Agrawal N; Garg J; Mohandas R; Gupta T; Segal M
    Am J Med Sci; 2015 Aug; 350(2):147-51. PubMed ID: 26086152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of left ventricular myocardial remodeling in patients with chronic renal disease, and the effects of spironolactone therapy].
    Karabaeva AZh; Esaian AM; Kaiukov IG
    Klin Med (Mosk); 2007; 85(12):44-8. PubMed ID: 18318166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Effects of Low-Dose Spironolactone on Chronic Dialysis Patients: A Randomized Placebo-Controlled Study.
    Lin C; Zhang Q; Zhang H; Lin A
    J Clin Hypertens (Greenwich); 2016 Feb; 18(2):121-8. PubMed ID: 26224543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extrasystoles but does not change endothelial function or heart rate variability in chronic heart failure.
    Farquharson CA; Struthers AD
    Heart; 2002 Nov; 88(5):475-80. PubMed ID: 12381637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of beta-blocker dose with serum procollagen concentrations and cardiac response to spironolactone in patients with heart failure.
    Cavallari LH; Momary KM; Groo VL; Viana MA; Camp JR; Stamos TD
    Pharmacotherapy; 2007 Jun; 27(6):801-12. PubMed ID: 17542763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.